GGrantIndex
← Search

Boston University-University of Liberia Partnership to Enhance Emerging Epidemic Viruses Research in Liberia (BULEEVR)

$297,413D43FY2025TWNIH

Boston University Medical Campus, Boston MA

Investigators

Abstract

Abstract/Summary The Boston University and University of Liberia Emerging and Epidemic Virus Research (BULEEVR) training program is a collaboration and partnership with key stakeholders in Liberia including the University of Liberia, College of Health Sciences (ULCHS), Liberian Institute of Biomedical Research, National Public Health Institute of Liberia, Partnership for Research on Ebola Virus in Liberia, and Research Sustainability Initiative in Liberia to create research and PhD training opportunities in basic, translational and public health sciences on emerging pathogens with a focus on viral pathogenesis in Liberia. This renewal will continue our successful program to train Liberian scientists and create a culture of science amongst the Liberian research community. Starting in 2019, BULEEVR, in partnership with stakeholders in Liberia, has provided mentorship and training for seven BULEEVR scholars. Our trainees have exceeded expectations with four matriculating into PhD programs and one completing a master's degree at BU before matriculating into a PhD program. In addition, over the last 5 years, during and post-COVID, we organized workshops and seminars that focused on emerging and endemic infectious diseases that are health concerns for Liberia, as well as journal clubs and research-in-progress to foster scientific discussions amongst partners. Goals for the renewal include to continue to support and create scientific career paths for BULEEVR trainees in clinical, translational and basic science related to virology, immunology and epidemiology, to expand collaborations between Liberian and BU scientists to create research opportunities in Liberia, to train the next generation of BULEEVR scholars at the ULCHS, and to collaborate with ULCHS to assure robust in-country PhD training programs. A priority for BULEEVR and ULCHS for the next cycle is to support research and training on emerging infectious diseases in Liberia to minimize training time outside of Liberia and assure a smooth and mentored transition from PhD training towards independence with sustainable research projects. Aims for BULEEVR are: 1) increase research competencies by training Liberian scientists in basic, translational, and clinical sciences with a focus on emerging and endemic pathogenic viruses; 2) assist with implementation of PhD training at ULCHS; and 3) foster collaborative research in emerging and endemic viral diseases to support PhD training and develop independent careers in Liberia. Successful completion of these aims will build a community of Liberian scientist including the next generation of teachers, research leaders and mentors that will support a culture of science and in-country training opportunities for PhD-level Liberian researchers.

View original record on NIH RePORTER →